Unlocking the benefits of Drug Master File filing in the Indian pharmaceutical industries
Indian Journal of Pharmacology · 2024
DOI: 10.4103/ijp.ijp_297_23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Pharmacology, 2024. Verfasst von Rahul Pathak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs, Mankind Pharma Limited, New Delhi, India. Hauptthemen laut MEDLINE: Drug Industry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Ensuring the safety and quality of drugs is a crucial component for the development of any pharmaceutical industry. This requires stringent regulation in the process of drug manufacturing and marketing. A Drug Master File (DMF) serves as a comprehensive document containing information about the quality, safety, and manufacturing procedure/facility of a drug or drug substance. Many countries with highly regulated markets use the DMF system extensively to protect their intellectual property rights while providing accurate and detailed information about their products to regulatory bodies. In India, the regulatory body, the Central Drug Standard Control Organization, does not currently mandate the submission of a DMF. However, adopting a DMF system may have immense benefits to regulatory bodies, pharmaceutical industries, as well as to patients. This review aims to provide a comprehensive overview of DMF and highlight the significance of its adoption in India.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Affairs, Mankind Pharma Limited, New Delhi, India.
Zitieren
APA
Pathak, R., Singal, R., Mitra, S., Koul, S., & Sharma, S. (2024). Unlocking the benefits of Drug Master File filing in the Indian pharmaceutical industries. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_297_23
Vancouver
Pathak R, Singal R, Mitra S, Koul S, Sharma S. Unlocking the benefits of Drug Master File filing in the Indian pharmaceutical industries. Indian Journal of Pharmacology. 2024. doi:10.4103/ijp.ijp_297_23
BibTeX
@article{Pathak2024,
author = {Pathak, Rahul and Singal, Rajat and Mitra, Sandip and Koul, Sanjay and Sharma, Supriya},
title = {Unlocking the benefits of Drug Master File filing in the Indian pharmaceutical industries},
journal = {Indian Journal of Pharmacology},
year = {2024},
doi = {10.4103/ijp.ijp_297_23}
}
EUVIMED